Company profile
immuneAdvice GmbH
We visualize immune cells to guide immunotherapy.
- Industry
- Biotechnology Research
- Employees
- 1
- Headquarters
- Reutlingen/ Tübingen
- Founded
- 2024
- Office locations
- 1
immuneAdvice GmbH company summary
immuneAdvice GmbH is a company in the Biotechnology Research industry, headquartered in Reutlingen/ Tübingen, founded in 2024. On LinkedIn the company has around 1 employees.
What technology does immuneAdvice GmbH use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About immuneAdvice GmbH
immuneAdvice is biotechnology startup developing immune cell tracers (ICE-Ts) for the non-invasive detection of immune cells in the body. immuneAdvice is a spin-off of the NMI Natural and Medical Sciences Institute at the University of Tübingen and the Werner Siemens Imaging Center Tübingen. Medical need: immunotherapies have revolutionized cancer treatment in recent years, but their success has been severely limited by the unpredictability of individual responses. The high proportion of unsuccessful immunotherapies results not only in lost time for patients, but also in enormous additional costs for the healthcare system. In an aging society with an increasing number of cancer patients and new immunotherapies, patient stratification is essential. Our technology: immuneAdvice develops single domain antibody (VHHs)-based novel tracer molecules (ICE-Ts) for the detection of immune cell populations in non-invasive clinical imaging. ICE-Ts visualize the dynamic distribution of immune cells and their activation state with high spatial and temporal resolution, allowing individualized assessment of the response to immunotherapy. Our goal is to establish a therapeutic diagnostic that predicts the efficacy of current and future immunotherapies and evaluates them during therapy. immuneAdvice is funded by EXIST - Existenzgründungen aus der Wissenschaft to complete the preclinical development of the first ICE-T. A first human trial is planned to start in 2025.
Where is immuneAdvice GmbH located?
immuneAdvice GmbH lists 1 location.
Compare companies similar to immuneAdvice GmbH
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
immuneAdvice GmbH immune-advice.com | Biotechnology Research | 1 | 2024 | Reutlingen/ Tübingen |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about immuneAdvice GmbH
What does immuneAdvice GmbH do?
immuneAdvice is biotechnology startup developing immune cell tracers (ICE-Ts) for the non-invasive detection of immune cells in the body. immuneAdvice is a spin-off of the NMI Natural and Medical Sciences Institute at the University of Tübingen and the Werner Siemens Imaging Center Tübingen. Medical need: immunotherapies have revolutionized cancer treatment in recent years, but their success has been severely limited by the unpredictability of individual responses. The high proportion of unsuccessful immunotherapies results not only in lost time for patients, but also in enormous additional costs for the healthcare system. In an aging society with an increasing number of cancer patients and new immunotherapies, patient stratification is essential. Our technology: immuneAdvice develops single domain antibody (VHHs)-based novel tracer molecules (ICE-Ts) for the detection of immune cell populations in non-invasive clinical imaging. ICE-Ts visualize the dynamic distribution of immune cells and their activation state with high spatial and temporal resolution, allowing individualized assessment of the response to immunotherapy. Our goal is to establish a therapeutic diagnostic that predicts the efficacy of current and future immunotherapies and evaluates them during therapy. immuneAdvice is funded by EXIST - Existenzgründungen aus der Wissenschaft to complete the preclinical development of the first ICE-T. A first human trial is planned to start in 2025.
How many employees does immuneAdvice GmbH have?
immuneAdvice GmbH has around 1 employees on LinkedIn.
Where is immuneAdvice GmbH headquartered?
immuneAdvice GmbH is headquartered in Reutlingen/ Tübingen.
When was immuneAdvice GmbH founded?
immuneAdvice GmbH was founded in 2024.
Build a lead list from companies like immuneAdvice GmbH
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.